It’s time to double-check your medicine cabinets.
Pfizer issued a voluntary recall of five lots of popular blood pressure medication Accupril.
This comes after Pfizer recalled the same medication and two of its generic versions over the same cancer-causing impurity in March. . The medication was recalled due to the presence of a nitrosamine, N-nitroso-quinapril—impurities that may increase the risk of cancer after prolonged exposure above acceptable levels.. The drug is also prescribed to manage heart failure when taken with conventional therapies, like diuretics or digitalis.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Faces Push to Loosen Rules for Sperm DonationsThe FDA relaxed its rules regarding blood donation by men who have sex with men. Now the agency is being asked to change its sperm donation rules.
Read more »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Read more »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Read more »
FDA approves first COVID-19 treatment for children under 12 years oldThe FDA gave approval to the use of Veklury (remdesivir) for children 28 days and older who weigh at least 3 kilograms (about 7 pounds).
Read more »
FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Read more »
Coronavirus: FDA approves first COVID-19 treatment for children younger than 12The FDA said Monday it expanded the approval of Veklury to include pediatric patients in certain circumstances.
Read more »